Ellen Lambrix and Adam Coughlin from Bristows' Commercial IP team attended the BioIntegrates conference in London on 16 May 2023. With...

First published in Kluwer Copyright Blog, May 2023, patent litigator Aida Tohala discusses the legal concept of plausibility following...

The Unitary Patent system is finally due to go live on 1 June 2023 and transitional measures are already in place to assist applicants...

The Guardian reported yesterday that the first UK baby with DNA from three people has been born in IVF treatment. In 2017, the Newcastle...

The Government has confirmed in its recent Response to Consultation for Legislative Proposals for Clinical Trials that it will be...

This article is the sixth in our "Trends in digital health" series. Anyone who has spent more than a passing moment browsing a smartphone...

This article is the fifth in our "Trends in digital health" series. Lord O’Shaughnessy has been asked to make recommendations to the UK...

Cell and gene therapies (CGTs) are highly complex and sophisticated technologies with a lot of constituent parts. To bring a product to...

This article is the fourth in our "Trends in digital health" series. Synthetic data itself is not a new concept – on some analyses, 2023...

An ambitious new project is currently underway with the goal of becoming the UK’s “largest ever health research programme”.[1] Up to 5...

This HFEA consultation, launched on Tuesday, is important not only for IVF clinics, but to all those working in the fields of...

The life sciences industry saw unprecedented levels of activity in 2020 and 2021 in the fight against Covid. In 2022 we saw a different...